Corneal Stroma Cell Density Evolution in Keratoconus Corneas Following the Implantation of Adipose Mesenchymal Stem Cells and Corneal Laminas: An In Vivo Confocal Microscopy Study.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
09 04 2020
Historique:
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 22 8 2020
Statut: ppublish

Résumé

To report the corneal stroma cell density evolution identified by in vivo corneal confocal microscopy in humans using injected autologous adipose-derived adult stem cells (ADASCs) and corneal decellularized laminas in corneas with advanced keratoconus. Interventional prospective, consecutive, randomized, comparative series of cases. A total of 14 keratoconic patients were randomly distributed into three groups for three types of surgical interventions: group 1 (G-1), autologous ADASC implantation (n = 5); group 2 (G-2), decellularized human corneal stroma (n = 5); and group 3 (G-3), autologous ADASCs + decellularized human corneal stroma (n = 4). A gradual and significant increase (P < 0.001) was observed in the cellularity in the anterior and posterior stroma of patients in G-1, G-2, and G-3 a year after the surgery in comparison with the preoperative density level. The same result was observed at the mid-corneal stroma in G-1 and at the anterior and posterior surfaces and within the laminas in G-2 and G-3. The cell density of patients receiving ADASC recellularized laminas (G-3) was statistically significantly higher (P = 0.011) at the anterior surface and within the lamina (P = 0.029) and at the posterior surface than in those implanted only with decellularized laminas (G-2). A significant increase in cell density occurred up to 1 postoperative year at the corneal stroma following the implantation of ADASCs alone, as well as in those cases implanted with decellularized and recellularized laminas at the different levels of the analysis. However, this increase was significantly higher in the ADASC recellularized laminas.

Identifiants

pubmed: 32301973
pii: 2764831
doi: 10.1167/iovs.61.4.22
pmc: PMC7401496
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22

Références

Am J Ophthalmol. 2019 Jul;203:53-68
pubmed: 30772348
Cornea. 2017 Aug;36(8):952-960
pubmed: 28486314
Stem Cells. 2007 Nov;25(11):2896-902
pubmed: 17901396
J Cell Sci. 1999 Mar;112 ( Pt 5):613-22
pubmed: 9973596
J Refract Surg. 2001 Jan-Feb;17(1):69-73
pubmed: 11201780
Eye Vis (Lond). 2016 Jan 18;3:2
pubmed: 26783544
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1948-55
pubmed: 19907021
Cornea. 1994 Jan;13(1):73-7
pubmed: 8131410
J Cataract Refract Surg. 2011 Mar;37(3):552-68
pubmed: 21333878
Acta Ophthalmol (Copenh). 1987 Oct;65(5):545-50
pubmed: 3425262
Cornea. 2009 Aug;28(7):774-9
pubmed: 19574909
Stem Cells. 2009 Jul;27(7):1635-42
pubmed: 19544455
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7352-61
pubmed: 26562169
Ophthalmology. 2008 May;115(5):845-50
pubmed: 17825419
Am J Ophthalmol. 2002 Nov;134(5):689-95
pubmed: 12429244
Stem Cells. 2008 Feb;26(2):570-9
pubmed: 18065394
PLoS One. 2010 May 19;5(5):e10707
pubmed: 20502663
Am J Ophthalmol. 2018 Feb;186:47-58
pubmed: 29103962
Invest Ophthalmol Vis Sci. 2001 Feb;42(2):333-9
pubmed: 11157863

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH